chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Skin haemorrhage
Clinical narrative: after first shot this seemed to get worse, it was itching more and more and turned into a rash, like it bleeds a little when you scratch; When scratching the itchiness it bleeds; This spontaneous case was reported by a consumer and describes the occurrence of CONDITION AGGRAVATED (after first shot this seemed to get worse, it was itching more and more and turned into a rash, like it bleeds a little when you scratch) and SKIN HAEMORRHAGE (When scratching the itchiness it bleeds) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Allergy, Asthma, Blood pressure abnormal (UNSPECIFIED ALLERGIES), Chronic fatigue syndrome, Anxiety, Fibromyalgia, Depression, Knee pain and Itchy rash (prescribed Thimerosal Cream, like a cortisone cream on 17-Feb-2021) since February 2021. Concomitant products included DESVENLAFAXINE SUCCINATE (PRISTIQ) for Antidepressant drug clearance NOS, CLONAZEPAM (KLONOPIN) for Anxiety, MONTELUKAST SODIUM (SINGULAIR) for Asthma, PROPRANOLOL for Blood pressure management, THIMEROSAL from 17-Feb-2021 to an unknown date for Itchy rash, SILODOSIN and PARACETAMOL (TYLENOL) for Knee pain, ESCITALOPRAM OXALATE (LEXAPRO) for an unknown indication.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced CONDITION AGGRAVATED (after first shot this seemed to get worse, it was itching more and more and turned into a rash, like it bleeds a little when you scratch) and SKIN HAEMORRHAGE (When scratching the itchiness it bleeds). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at a dose of 1 dosage form; HYDROCORTISONE at a dose of 1 dosage form and KETOCONAZOLE at a dose of 1 dosage form. At the time of the report, CONDITION AGGRAVATED (after first shot this seemed to get worse, it was itching more and more and turned into a rash, like it bleeds a little when you scratch) and SKIN HAEMORRHAGE (When scratching the itchiness it bleeds) had not resolved.            The reporter did not specify if additional treatment began (with Benadryl, Hydrocortisone cream, and Ketoconazole shampoo) before or after the second dose administration of mRNA-1273.   This case was linked to MOD-2021-075575.
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Fatigue, Nausea
Clinical narrative: Consumer thought she get expired vaccine at the first time; Fatigue; Nausea for a day; This spontaneous case was reported by a consumer and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Consumer thought she get expired vaccine at the first time), FATIGUE (Fatigue) and NAUSEA (Nausea for a day) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001B21A and 003B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 16-Mar-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Consumer thought she get expired vaccine at the first time), FATIGUE (Fatigue) and NAUSEA (Nausea for a day). On 16-Mar-2021, EXPIRED PRODUCT ADMINISTERED (Consumer thought she get expired vaccine at the first time) had resolved. On 17-Mar-2021, FATIGUE (Fatigue) and NAUSEA (Nausea for a day) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication were reported.  The reporter stated that she did not take any medication for treating the effects.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia oral
Clinical narrative: Numbness over the lips and then moved to tip of the tongue; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA ORAL (Numbness over the lips and then moved to tip of the tongue) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced HYPOAESTHESIA ORAL (Numbness over the lips and then moved to tip of the tongue). On 29-Mar-2021, HYPOAESTHESIA ORAL (Numbness over the lips and then moved to tip of the tongue) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was reported.
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Decreased appetite, Dizziness
Clinical narrative: in bed most of the time; started to get dizzy and can't get up; started to loose appetite; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (started to loose appetite), ASTHENIA (in bed most of the time) and DIZZINESS (started to get dizzy and can't get up) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006M20A and 032L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 19-Feb-2021, the patient experienced DECREASED APPETITE (started to loose appetite). On an unknown date, the patient experienced ASTHENIA (in bed most of the time) and DIZZINESS (started to get dizzy and can't get up). At the time of the report, DECREASED APPETITE (started to loose appetite) had not resolved and ASTHENIA (in bed most of the time) and DIZZINESS (started to get dizzy and can't get up) outcome was unknown. Not Provided          No concomitant medications were provided by the reporter. No treatments medications were reported. I t was reported that she shouldn't be having side effects since it's been this long.   Most recent FOLLOW-UP information incorporated above includes: On 05-May-2021: Significant follow up: outcome of event updated and reporter contact details added.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Reaction to the Covid shot; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Reaction to the Covid shot) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced VACCINATION COMPLICATION (Reaction to the Covid shot). At the time of the report, VACCINATION COMPLICATION (Reaction to the Covid shot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported. No treatment was reported.   This case was linked to US-MODERNATX, INC.-MOD-2021-075607 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 15-Apr-2021: No specific follow-up information recorded.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-075607:Same reporter/ Different Patient
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Epistaxis, Fatigue, Lacrimation increased, Myalgia, Nausea
Clinical narrative: This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of EPISTAXIS (Nose bleeds almost everyday), LACRIMATION INCREASED (runny eyes), SNEEZING (sneezing), FATIGUE (Fatigue) and MYALGIA (body ache) in a 45-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Allergy to nuts (Anaphylaxis with hazelnut.) and Food allergy (Anaphylaxis with celery.).    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Mar-2021, the patient experienced EPISTAXIS (Nose bleeds almost everyday), LACRIMATION INCREASED (runny eyes) and SNEEZING (sneezing). On 25-Mar-2021, the patient experienced FATIGUE (Fatigue), MYALGIA (body ache) and NAUSEA (nausea). At the time of the report, EPISTAXIS (Nose bleeds almost everyday), LACRIMATION INCREASED (runny eyes) and SNEEZING (sneezing) had not resolved and FATIGUE (Fatigue), MYALGIA (body ache) and NAUSEA (nausea) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  Treatment of the event nose bleeding includes, cauterization of nose.   This case was linked to MOD-2021-107411 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 05-May-2021: Patient demographics,  outcome of events, second dose information with events updated.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Sneezing
Clinical narrative: This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of EPISTAXIS (Nose bleeds almost everyday), LACRIMATION INCREASED (runny eyes), SNEEZING (sneezing), FATIGUE (Fatigue) and MYALGIA (body ache) in a 45-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Allergy to nuts (Anaphylaxis with hazelnut.) and Food allergy (Anaphylaxis with celery.).    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Mar-2021, the patient experienced EPISTAXIS (Nose bleeds almost everyday), LACRIMATION INCREASED (runny eyes) and SNEEZING (sneezing). On 25-Mar-2021, the patient experienced FATIGUE (Fatigue), MYALGIA (body ache) and NAUSEA (nausea). At the time of the report, EPISTAXIS (Nose bleeds almost everyday), LACRIMATION INCREASED (runny eyes) and SNEEZING (sneezing) had not resolved and FATIGUE (Fatigue), MYALGIA (body ache) and NAUSEA (nausea) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  Treatment of the event nose bleeding includes, cauterization of nose.   This case was linked to MOD-2021-107411 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 05-May-2021: Patient demographics,  outcome of events, second dose information with events updated.
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Exposure to SARS-CoV-2
Clinical narrative: tested positive for COVID19; Exposed to many family members with Positive COVID19 virus; This spontaneous case was reported by a physician and describes the occurrence of EXPOSURE TO SARS-COV-2 (Exposed to many family members with Positive COVID19 virus) and COVID-19 (tested positive for COVID19) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Mar-2021, the patient experienced EXPOSURE TO SARS-COV-2 (Exposed to many family members with Positive COVID19 virus). On an unknown date, the patient experienced COVID-19 (tested positive for COVID19). At the time of the report, EXPOSURE TO SARS-COV-2 (Exposed to many family members with Positive COVID19 virus) and COVID-19 (tested positive for COVID19) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Mar-2021, SARS-CoV-2 test: positive positive Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication were reported.  No treatment information was reported.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site induration
Clinical narrative: Red blotchy spot at and around injection site; Slight bump; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE ERYTHEMA (Red blotchy spot at and around injection site) and INJECTION SITE INDURATION (Slight bump) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037K20A and 032L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported.).   On 23-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 24-Dec-2020, the patient experienced INJECTION SITE ERYTHEMA (Red blotchy spot at and around injection site) and INJECTION SITE INDURATION (Slight bump). At the time of the report, INJECTION SITE ERYTHEMA (Red blotchy spot at and around injection site) and INJECTION SITE INDURATION (Slight bump) had not resolved.            No concomitant medication or treatment information was provided.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: soreness at site of injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (soreness at site of injection) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included HYDROXYCHLOROQUINE and MELOXICAM for an unknown indication.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced VACCINATION SITE PAIN (soreness at site of injection). At the time of the report, VACCINATION SITE PAIN (soreness at site of injection) outcome was unknown.            No concomitant medications were reported.  No treatment medications were reported.  Patient took second dose on 12-APR-2021.  Action taken with mRNA-1273 in response to the events was not Applicable.   This case was linked to MOD-2021-075612 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Lymphadenopathy, Retching, Toothache
Clinical narrative: Excruciating pain to tooth; Dry heaving; Headaches; Fatigue; Lymph nodes swollen-right; This spontaneous case was reported by a consumer and describes the occurrence of TOOTHACHE (Excruciating pain to tooth), RETCHING (Dry heaving), HEADACHE (Headaches), FATIGUE (Fatigue) and LYMPHADENOPATHY (Lymph nodes swollen-right) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, the patient experienced TOOTHACHE (Excruciating pain to tooth), RETCHING (Dry heaving), HEADACHE (Headaches), FATIGUE (Fatigue) and LYMPHADENOPATHY (Lymph nodes swollen-right). At the time of the report, TOOTHACHE (Excruciating pain to tooth), RETCHING (Dry heaving), HEADACHE (Headaches), FATIGUE (Fatigue) and LYMPHADENOPATHY (Lymph nodes swollen-right) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  No treatment information was provided.   Reporter did not allow further contact
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling abnormal, Flushing, Pain in extremity
Clinical narrative: foggy in head; flushed feeling but not fever; tired; very sore arm; This spontaneous case was reported by a non-health professional and describes the occurrence of FEELING ABNORMAL (foggy in head), FLUSHING (flushed feeling but not fever), FATIGUE (tired) and PAIN IN EXTREMITY (very sore arm) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included MAGNESIUM for Magnesium supplementation, CALCIUM and CURCUMIN (TURMERIC MERIVA) for Supplementation therapy, BUPROPION HYDROCHLORIDE (WELLBUTRIN), AMLODIPINE, HYDROCHLOROTHIAZIDE, ROSUVASTATIN CALCIUM (CRESTOR) and ASPIRIN [ACETYLSALICYLIC ACID] for an unknown indication.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced FEELING ABNORMAL (foggy in head), FLUSHING (flushed feeling but not fever), FATIGUE (tired) and PAIN IN EXTREMITY (very sore arm). In March 2021, FEELING ABNORMAL (foggy in head), FLUSHING (flushed feeling but not fever), FATIGUE (tired) and PAIN IN EXTREMITY (very sore arm) had resolved.            Concomitant medications included probiotics Action taken with mRNA-1273 in response to the events was not applicable.  No treatment medications were provided.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.    This case was linked to MOD-2021-075617 (Patient Link).
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Pain, Pyrexia
Clinical narrative: Body aches; Fever; Headache; Tiredness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Body aches), PYREXIA (Fever), HEADACHE (Headache) and FATIGUE (Tiredness) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040R21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included ATORVASTATIN for an unknown indication.    On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, the patient experienced PAIN (Body aches), PYREXIA (Fever), HEADACHE (Headache) and FATIGUE (Tiredness). The patient was treated with IBUPROFEN (ADVIL 12 HOUR) at a dose of 1 dosage form. At the time of the report, PAIN (Body aches), PYREXIA (Fever), HEADACHE (Headache) and FATIGUE (Tiredness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: U
Vaccine: COVID19
Symptoms: Abdominal discomfort, Heart rate, Illness, Pyrexia, Tachycardia
Clinical narrative: heart rate 130; Pretty ill; Stomach upset; Fever; This spontaneous case was reported by a consumer and describes the occurrence of TACHYCARDIA (heart rate 130), ILLNESS (Pretty ill), ABDOMINAL DISCOMFORT (Stomach upset) and PYREXIA (Fever) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included RA. Concomitant products included TOFACITINIB CITRATE (XELJANZ) for RA.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced TACHYCARDIA (heart rate 130), ILLNESS (Pretty ill), ABDOMINAL DISCOMFORT (Stomach upset) and PYREXIA (Fever). At the time of the report, TACHYCARDIA (heart rate 130), ILLNESS (Pretty ill), ABDOMINAL DISCOMFORT (Stomach upset) and PYREXIA (Fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Heart rate: 130 resting (Inconclusive) 130 resting.         This case was linked to -MODERNATX, INC.-MOD-2021-075625 (E2B Linked Report).; Sender's Comments:  -MODERNATX, INC.-MOD-2021-075625:Dose 1 case
Sex: F
Vaccine: COVID19
Symptoms: Headache, Migraine, Vaccination site erythema, Vaccination site swelling
Clinical narrative: Migraine; lingering headache; Arm had a red and swollen area; Arm had a red and swollen area; This spontaneous case was reported by an other health care professional and describes the occurrence of MIGRAINE (Migraine), HEADACHE (lingering headache), VACCINATION SITE ERYTHEMA (Arm had a red and swollen area) and VACCINATION SITE SWELLING (Arm had a red and swollen area) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Migraine (she has migraines).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MIGRAINE (Migraine) and HEADACHE (lingering headache). an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (Arm had a red and swollen area) and VACCINATION SITE SWELLING (Arm had a red and swollen area). At the time of the report, MIGRAINE (Migraine) and HEADACHE (lingering headache) was resolving and VACCINATION SITE ERYTHEMA (Arm had a red and swollen area) and VACCINATION SITE SWELLING (Arm had a red and swollen area) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-075578, US-MODERNATX, INC.-MOD-2021-075578 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 18-May-2021: Follow-up contains no new information. On 21-Jul-2021: No new information: When requested to provide additional information about the patient's experience, the responder stated she was unable to provide any further information.; Sender's Comments:  MOD-2021-075578:Same reporter /Different patient US-MODERNATX, INC.-MOD-2021-075578:Same reporter/ Different Patient
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Myalgia, Pyrexia
Clinical narrative: shoulder was incredibly painful to move (Pain travelled all the way down to the elbow); Little achiness; little feverish; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (shoulder was incredibly painful to move (Pain travelled all the way down to the elbow)), MYALGIA (Little achiness) and PYREXIA (little feverish) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced ARTHRALGIA (shoulder was incredibly painful to move (Pain travelled all the way down to the elbow)), MYALGIA (Little achiness) and PYREXIA (little feverish). On 19-Mar-2021, ARTHRALGIA (shoulder was incredibly painful to move (Pain travelled all the way down to the elbow)), MYALGIA (Little achiness) and PYREXIA (little feverish) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Mar-2021, Body temperature: Inconclusive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information included paracetamol.   Most recent FOLLOW-UP information incorporated above includes: On 05-May-2021: patient denied to share contact information and asked to followup via phone.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Dizziness, Fatigue, Headache, Heart rate
Clinical narrative: Dizzy/ lightheadedness; Resting heart rate of 105; Body aches; Fever of 100.1 F; Headache; Itchy throat; Really tired; Injection arm is sore; This spontaneous case was reported by a consumer and describes the occurrence of THROAT IRRITATION (Itchy throat), DIZZINESS (Dizzy/ lightheadedness), PALPITATIONS (Resting heart rate of 105), FATIGUE (Really tired) and VACCINATION SITE PAIN (Injection arm is sore) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included HYDROXYCHLOROQUINE and MELOXICAM for an unknown indication.   On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Apr-2021, the patient experienced THROAT IRRITATION (Itchy throat), FATIGUE (Really tired) and VACCINATION SITE PAIN (Injection arm is sore). On 13-Apr-2021, the patient experienced DIZZINESS (Dizzy/ lightheadedness), PALPITATIONS (Resting heart rate of 105), MYALGIA (Body aches), PYREXIA (Fever of 100.1 F) and HEADACHE (Headache). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, THROAT IRRITATION (Itchy throat), DIZZINESS (Dizzy/ lightheadedness), PALPITATIONS (Resting heart rate of 105), FATIGUE (Really tired), VACCINATION SITE PAIN (Injection arm is sore), MYALGIA (Body aches), PYREXIA (Fever of 100.1 F) and HEADACHE (Headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-Apr-2021, Body temperature: 100.1 (High) 100.1F. On 13-Apr-2021, Heart rate: 105 (High) 105.         This case was linked to MOD-2021-075592 (Patient Link).
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Palpitations, Pyrexia, Throat irritation, Vaccination site pain
Clinical narrative: Dizzy/ lightheadedness; Resting heart rate of 105; Body aches; Fever of 100.1 F; Headache; Itchy throat; Really tired; Injection arm is sore; This spontaneous case was reported by a consumer and describes the occurrence of THROAT IRRITATION (Itchy throat), DIZZINESS (Dizzy/ lightheadedness), PALPITATIONS (Resting heart rate of 105), FATIGUE (Really tired) and VACCINATION SITE PAIN (Injection arm is sore) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included HYDROXYCHLOROQUINE and MELOXICAM for an unknown indication.   On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Apr-2021, the patient experienced THROAT IRRITATION (Itchy throat), FATIGUE (Really tired) and VACCINATION SITE PAIN (Injection arm is sore). On 13-Apr-2021, the patient experienced DIZZINESS (Dizzy/ lightheadedness), PALPITATIONS (Resting heart rate of 105), MYALGIA (Body aches), PYREXIA (Fever of 100.1 F) and HEADACHE (Headache). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, THROAT IRRITATION (Itchy throat), DIZZINESS (Dizzy/ lightheadedness), PALPITATIONS (Resting heart rate of 105), FATIGUE (Really tired), VACCINATION SITE PAIN (Injection arm is sore), MYALGIA (Body aches), PYREXIA (Fever of 100.1 F) and HEADACHE (Headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-Apr-2021, Body temperature: 100.1 (High) 100.1F. On 13-Apr-2021, Heart rate: 105 (High) 105.         This case was linked to MOD-2021-075592 (Patient Link).
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Blister, Headache, Herpes zoster, Lip swelling, Paraesthesia
Clinical narrative: rash became blistery/shingles; became blistery.; head headache that felt "nervy; rash "straight ine" down her neck and appeared on right side of body; swelling of lips slightly; tingly; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of RASH (rash "straight ine" down her neck and appeared on right side of body), LIP SWELLING (swelling of lips slightly), PARAESTHESIA (tingly), HERPES ZOSTER (rash became blistery/shingles) and BLISTER (became blistery.) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included BUPROPION HYDROCHLORIDE (WELLBUTRIN), AMLODIPINE, HYDROCHLOROTHIAZIDE, ROSUVASTATIN CALCIUM (CRESTOR), CALCIUM, MAGNESIUM, TURMERIC [CURCUMA LONGA RHIZOME], ASPIRIN [ACETYLSALICYLIC ACID] and PROBIOTICS NOS for an unknown indication.    On 06-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Apr-2021, the patient experienced RASH (rash "straight ine" down her neck and appeared on right side of body), LIP SWELLING (swelling of lips slightly), PARAESTHESIA (tingly) and HEADACHE (head headache that felt "nervy). On 11-Apr-2021, the patient experienced HERPES ZOSTER (rash became blistery/shingles) and BLISTER (became blistery.). The patient was treated with CORTISONE (topical) for Rash, at a dose of 1 dosage form and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at a dose of 1 dosage form. At the time of the report, RASH (rash "straight ine" down her neck and appeared on right side of body), LIP SWELLING (swelling of lips slightly), PARAESTHESIA (tingly), HERPES ZOSTER (rash became blistery/shingles), BLISTER (became blistery.) and HEADACHE (head headache that felt "nervy) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Action taken with mRNA-1273 in response to the event was not applicable.     This case was linked to MOD-2021-075599, MOD-2021-075599 (Patient Link).
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: rash became blistery/shingles; became blistery.; head headache that felt "nervy; rash "straight ine" down her neck and appeared on right side of body; swelling of lips slightly; tingly; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of RASH (rash "straight ine" down her neck and appeared on right side of body), LIP SWELLING (swelling of lips slightly), PARAESTHESIA (tingly), HERPES ZOSTER (rash became blistery/shingles) and BLISTER (became blistery.) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included BUPROPION HYDROCHLORIDE (WELLBUTRIN), AMLODIPINE, HYDROCHLOROTHIAZIDE, ROSUVASTATIN CALCIUM (CRESTOR), CALCIUM, MAGNESIUM, TURMERIC [CURCUMA LONGA RHIZOME], ASPIRIN [ACETYLSALICYLIC ACID] and PROBIOTICS NOS for an unknown indication.    On 06-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Apr-2021, the patient experienced RASH (rash "straight ine" down her neck and appeared on right side of body), LIP SWELLING (swelling of lips slightly), PARAESTHESIA (tingly) and HEADACHE (head headache that felt "nervy). On 11-Apr-2021, the patient experienced HERPES ZOSTER (rash became blistery/shingles) and BLISTER (became blistery.). The patient was treated with CORTISONE (topical) for Rash, at a dose of 1 dosage form and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at a dose of 1 dosage form. At the time of the report, RASH (rash "straight ine" down her neck and appeared on right side of body), LIP SWELLING (swelling of lips slightly), PARAESTHESIA (tingly), HERPES ZOSTER (rash became blistery/shingles), BLISTER (became blistery.) and HEADACHE (head headache that felt "nervy) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Action taken with mRNA-1273 in response to the event was not applicable.     This case was linked to MOD-2021-075599, MOD-2021-075599 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Blood test, Platelet disorder
Clinical narrative: Low blood platelets; This spontaneous case was reported by a consumer and describes the occurrence of PLATELET DISORDER (Low blood platelets) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Rheumatoid arthritis. Concomitant products included TOFACITINIB CITRATE (XELJANZ) for Rheumatoid arthritis.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PLATELET DISORDER (Low blood platelets). At the time of the report, PLATELET DISORDER (Low blood platelets) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood test: (Low) Low platelet count.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medication were reported.  No treatment medication were reported.   This case was linked to US-MODERNATX, INC.-MOD-2021-075604 (E2B Linked Report). This case was linked to MOD-2021-075604 (Patient Link).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-075604:Dose 1 case
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Intentional product use issue
Clinical narrative: Trying to re-schedule the second shot; This spontaneous case was reported by a consumer and describes the occurrence of INTENTIONAL PRODUCT USE ISSUE (Trying to re-schedule the second shot) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, the patient experienced INTENTIONAL PRODUCT USE ISSUE (Trying to re-schedule the second shot). At the time of the report, INTENTIONAL PRODUCT USE ISSUE (Trying to re-schedule the second shot) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication use was provided by the reporter. No treatment of events was reported.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Muscular weakness, Pyrexia
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of MUSCULAR WEAKNESS (muscle weakness), CHILLS (chattering chill), HEADACHE (headache) and PYREXIA (fever) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028L20A and 002A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Feb-2021, the patient experienced MUSCULAR WEAKNESS (muscle weakness), CHILLS (chattering chill), HEADACHE (headache) and PYREXIA (fever). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 04-Feb-2021, MUSCULAR WEAKNESS (muscle weakness), CHILLS (chattering chill), HEADACHE (headache) and PYREXIA (fever) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication were reported.   This case was linked to US-MODERNATX, INC.-MOD-2021-075700 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-075700:second dose
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site induration, Vaccination site pain, Vaccination site pruritus
Clinical narrative: sore, itchy, hardened area at the injection site in the shape of circle; sore, itchy, hardened area at the injection site in the shape of circle; sore , itchy , hardened area at the injection site in the shape of circle; This spontaneous case was reported by a nurse and describes the occurrence of VACCINATION SITE INDURATION (sore, itchy, hardened area at the injection site in the shape of circle), VACCINATION SITE PRURITUS (sore, itchy, hardened area at the injection site in the shape of circle) and VACCINATION SITE PAIN (sore , itchy , hardened area at the injection site in the shape of circle) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     No Medical history was provided by reporter.     On 31-Mar-2021 at 5:50 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021 at 1:00 AM, the patient experienced VACCINATION SITE INDURATION (sore, itchy, hardened area at the injection site in the shape of circle), VACCINATION SITE PRURITUS (sore, itchy, hardened area at the injection site in the shape of circle) and VACCINATION SITE PAIN (sore , itchy , hardened area at the injection site in the shape of circle). At the time of the report, VACCINATION SITE INDURATION (sore, itchy, hardened area at the injection site in the shape of circle), VACCINATION SITE PRURITUS (sore, itchy, hardened area at the injection site in the shape of circle) and VACCINATION SITE PAIN (sore , itchy , hardened area at the injection site in the shape of circle) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information were not provided by the reporter. Concomitant medications were not reported by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 18-Jun-2021: Follow up ADR form received and patient demographics, vaccine facility information was added and vaccine administration details (route of administration & body site) were added On 16-Jul-2021: Email correspondence - No new information received
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Maternal exposure during breast feeding, Vaccination site erythema, Vaccination site mass, Vaccination site pain
Clinical narrative: Covid arm; lumpy; feels like scar tissue; itchy; golf size knot; red; painful to the touch; joint pain; maternal exposure during breastfeeding; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (Covid arm), VACCINATION SITE MASS (lumpy), VACCINATION SITE SCAR (feels like scar tissue), MATERNAL EXPOSURE DURING BREAST FEEDING (maternal exposure during breastfeeding) and VACCINATION SITE PRURITUS (itchy) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Apr-2021, the patient experienced MATERNAL EXPOSURE DURING BREAST FEEDING (maternal exposure during breastfeeding) and ARTHRALGIA (joint pain). On 13-Apr-2021, the patient experienced VACCINATION SITE REACTION (Covid arm), VACCINATION SITE MASS (lumpy), VACCINATION SITE SCAR (feels like scar tissue), VACCINATION SITE PRURITUS (itchy), VACCINATION SITE SWELLING (golf size knot), VACCINATION SITE ERYTHEMA (red) and VACCINATION SITE PAIN (painful to the touch). On 05-Apr-2021, MATERNAL EXPOSURE DURING BREAST FEEDING (maternal exposure during breastfeeding) had resolved. At the time of the report, VACCINATION SITE REACTION (Covid arm), VACCINATION SITE MASS (lumpy), VACCINATION SITE SCAR (feels like scar tissue), VACCINATION SITE PRURITUS (itchy), VACCINATION SITE SWELLING (golf size knot), VACCINATION SITE ERYTHEMA (red), VACCINATION SITE PAIN (painful to the touch) and ARTHRALGIA (joint pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication use was provided by the reporter.  No treatment of events was reported.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site reaction, Vaccination site scar, Vaccination site swelling
Clinical narrative: Covid arm; lumpy; feels like scar tissue; itchy; golf size knot; red; painful to the touch; joint pain; maternal exposure during breastfeeding; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (Covid arm), VACCINATION SITE MASS (lumpy), VACCINATION SITE SCAR (feels like scar tissue), MATERNAL EXPOSURE DURING BREAST FEEDING (maternal exposure during breastfeeding) and VACCINATION SITE PRURITUS (itchy) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Apr-2021, the patient experienced MATERNAL EXPOSURE DURING BREAST FEEDING (maternal exposure during breastfeeding) and ARTHRALGIA (joint pain). On 13-Apr-2021, the patient experienced VACCINATION SITE REACTION (Covid arm), VACCINATION SITE MASS (lumpy), VACCINATION SITE SCAR (feels like scar tissue), VACCINATION SITE PRURITUS (itchy), VACCINATION SITE SWELLING (golf size knot), VACCINATION SITE ERYTHEMA (red) and VACCINATION SITE PAIN (painful to the touch). On 05-Apr-2021, MATERNAL EXPOSURE DURING BREAST FEEDING (maternal exposure during breastfeeding) had resolved. At the time of the report, VACCINATION SITE REACTION (Covid arm), VACCINATION SITE MASS (lumpy), VACCINATION SITE SCAR (feels like scar tissue), VACCINATION SITE PRURITUS (itchy), VACCINATION SITE SWELLING (golf size knot), VACCINATION SITE ERYTHEMA (red), VACCINATION SITE PAIN (painful to the touch) and ARTHRALGIA (joint pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication use was provided by the reporter.  No treatment of events was reported.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Insomnia, Muscle spasms, Pain in extremity
Clinical narrative: Intense pain on her right thigh where the Femoral Artery goes; Having sleep disruptions; Can't get more than 5 hours sleep; Muscle cramps have intensified; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Intense pain on her right thigh where the Femoral Artery goes), INSOMNIA (Having sleep disruptions), INSOMNIA (Can't get more than 5 hours sleep), MUSCLE SPASMS (Muscle cramps have intensified) and FATIGUE (Fatigue) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Cramps (Patient reported having cramps before Vaccination).    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, the patient experienced INSOMNIA (Having sleep disruptions), INSOMNIA (Can't get more than 5 hours sleep), MUSCLE SPASMS (Muscle cramps have intensified) and FATIGUE (Fatigue). On 04-Apr-2021, the patient experienced PAIN IN EXTREMITY (Intense pain on her right thigh where the Femoral Artery goes). On 04-Apr-2021, PAIN IN EXTREMITY (Intense pain on her right thigh where the Femoral Artery goes) had resolved. At the time of the report, INSOMNIA (Having sleep disruptions), INSOMNIA (Can't get more than 5 hours sleep), MUSCLE SPASMS (Muscle cramps have intensified) and FATIGUE (Fatigue) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported. Treatment medication was not provided by the reporter. The patient stated that she is determined to take second dose and then her Cardiologist would Scan her to monitor what's going.   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: bad headaches; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (bad headaches) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEADACHE (bad headaches). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, HEADACHE (bad headaches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication details was reported.
Sex: U
Vaccine: COVID19
Symptoms: Myalgia, Pain in extremity
Clinical narrative: Pain in the arm; Body aches; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in the arm) and MYALGIA (Body aches) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Pain in the arm) and MYALGIA (Body aches). At the time of the report, PAIN IN EXTREMITY (Pain in the arm) and MYALGIA (Body aches) outcome was unknown. Not Related      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       concomitant medicines was not reported by reporter   treatment information was not provided   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to US-MODERNATX, INC.-MOD-2021-074984 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-074984:Mother case